Recall: Camber Pharmaceuticals Montelukast Sodium Tablets, USP 10mg
On 2018-09-05, the FDA announced that Camber Pharmaceuticals is conducting a recall on Montelukast Sodium Tablets, USP 10mg due to a possible lack of proper labeling. The recalled products were sold under the brand name(s) Camber Pharmaceuticals during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 2 drugs recalls due to potential lack of proper labeling, including children's advil suspension bubble gum flavored 4 fl oz bottle, alka-seltzer plus and more. Additionally, there have been 27 drug and medical device recalls due to other health hazards as well as 71 food recalls.
Company Contact Information:
Name: Camber Pharmaceuticals
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Montelukast Sodium Tablets, USP 10mg
Brand Name(s): Camber Pharmaceuticals
Reason for Recall: Product label mix up/may contain Losartan Potassium Tablets
Official Recall Date: 2018-09-05
Additional information provided by the FDA.gov:
Camber Pharmaceuticals, Inc. is voluntarily recalling one single lot of Montelukast Sodium Tablets, USP 10mg, to the consumer level. This recall of one batch of Montelukast Sodium Tablets, USP 10mg, lot# MON17384 Exp. 12/31/2019, was prompted because a complaint of a sealed bottle labeled as Montelukast 10mg 30ct found to contain 90 tablets of Losartan Potassium Tablets, USP 50mg. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.